US Trade Gap Hits New Record in January as Tariff Fears Loomed
The U.S. trade deficit surged to a new record in January, government data showed Thursday, as imports spiked while tariff worries flared in the month of President Donald Trump’s inauguration.
Trump returned to the White House this year with pledges to ease cost-of-living pressures for voters, but on the campaign trail he also raised the possibility of sweeping levies across U.S.
» Read more about: US Trade Gap Hits New Record in January as Tariff Fears Loomed »
Read MoreWhat does Nvidia stock chart say as sell-off continues?
The stock price on an Nvidia (NVDA) chart is usually known for being up and to the right.
That’s not the case right now as the post-earnings Nvidia sell-off rages on.
Nvidia stock is down 9.8% since the company’s fourth quarter earnings results on Feb.
» Read more about: What does Nvidia stock chart say as sell-off continues? »
Read MoreJD.com Target of Unusually High Options Trading (NASDAQ:JD)
JD.com, Inc. (NASDAQ:JD – Get Free Report) was the target of unusually large options trading on Wednesday. Investors acquired 130,770 call options on the company. This represents an increase of 58% …
» Read more about: JD.com Target of Unusually High Options Trading (NASDAQ:JD) »
Read MoreStock futures fall on Sunday evening after S&P 500's worst week since September: Live updates
Stock futures moved lower on Sunday evening ahead of a packed week of economic data, with investors smarting from losses in early March.
Futures for the S&P 500 fell 0.5%, while Nasdaq 100 futures dropped 0.6%. Futures tied to the Dow Jones Industrial Average slipped 135 points,
Read MoreThe Burst
Market Commentary: The Meteoric Rise of Eli Lilly
Did you know that Eli Lilly and other pharmaceutical companies have sold approximately 10.6 million shots of obesity drug doses in the U.S. in a single month? The rise of these injectable weight loss medications is so powerful that it’s causing investors to question the future of even staple food and beverage stocks.
While this aspect alone could secure Eli Lilly as the pharmaceutical golden goose you’ve been looking for there is much more than meets the eye.
» Read more about: Market Commentary: The Meteoric Rise of Eli Lilly »
Read MoreThe Ivy
Is a 34.6% Annual Return a Slam Dunk?
The old fox Warren Buffett might still have the midas touch after all. One of his favorite stocks in recent years has been Occidental Petroleum, and it’s been on a tear recently.
A quick look at the chart reveals that the stock has broken out to the upside, above an old yet key resistance level.
» Read more about: Is a 34.6% Annual Return a Slam Dunk? »
Read MoreThe Spotlight
